(For treatment side effects and complications only)
Apalutamide Prostate Cancer V1.0
Cabazitaxel Prostate Cancer Protocol
Clinical Verification of Radium-223 in Prostate Cancer Protocol V1.1
Darolutamide Prostate Cancer Protocol V1.0
Darolutamide, Docetaxel and Androgen Deprivation Therapy (ADT) Hormone Sensitive Metastatic Prostate Cancer (mHSPC) V1.1
Degarelix (Firmagon) Protocol V1.0
Entrectinib - NTRK Gene Fusion-positive Solid Tumours ROS1-positive NSCLC Protocol V1.1
Larotrectinib NTRK Gene Fusion-positive Solid Tumours Protocol V1.0
Olaparib Prostate Cancer V1.1
Triptorelin Urology Protocol V1.0
Weekly Docetaxel Prostate Cancer (Unlicensed Use) Protocol V1.2